Last quarter (Q ), Parnell Pharmaceuticals's total revenue was AU$6.42M, an increase of 4.03% from the same quarter last year. In Q, Parnell Pharmaceuticals's net income was AU$-3.11M. See Parnell Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 18	Dec 17	Dec 16	Dec 15	Dec 14
Total Revenue	AU$ 15.02M	AU$ 26.55M	AU$ 19.13M	AU$ 19.97M	AU$ 19.89M	AU$ 8.01M
Cost of Revenue	AU$ 7.84M	AU$ 11.02M	AU$ 9.75M	AU$ 8.98M	AU$ 7.75M	AU$ 3.34M
Gross Profit	AU$ 7.18M	AU$ 15.52M	AU$ 9.38M	AU$ 10.99M	AU$ 12.15M	AU$ 4.67M
Operating Expense	AU$ 21.53M	AU$ 12.10M	AU$ 19.77M	AU$ 28.85M	AU$ 24.60M	AU$ 5.80M
Operating Income	AU$ -14.35M	AU$ 3.42M	AU$ -10.39M	AU$ -17.86M	AU$ -12.45M	AU$ -1.14M
Net Non Operating Interest Income Expense	AU$ -3.09M	AU$ -6.99M	AU$ -9.24M	AU$ -3.82M	AU$ -1.28M	AU$ -289.78K
Other Income Expense	-	AU$ 3.91M	AU$ -3.49M	AU$ -94.56K	-	-
Pretax Income	AU$ -17.54M	AU$ 337.04K	AU$ -23.12M	AU$ -21.68M	AU$ -13.74M	AU$ -1.43M
Tax Provision	AU$ -1.87K	AU$ 207.42K	AU$ 12.11K	AU$ 9.05K	AU$ 2.11K	AU$ 2.44K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	AU$ -17.53M	AU$ 129.62K	AU$ -23.13M	AU$ -21.69M	AU$ -13.74M	AU$ -1.43M
Basic EPS	AU$ -1.14	AU$ 0.01	AU$ -1.28	AU$ -1.37	AU$ -1.03	AU$ -0.11
Diluted EPS	AU$ -1.14	AU$ 0.01	AU$ -1.28	AU$ -1.37	AU$ -1.03	AU$ -0.11
Basic Average Shares	AU$ 47.37M	AU$ 18.03M	AU$ 18.14M	AU$ 15.81M	AU$ 13.28M	AU$ 13.28M
Diluted Average Shares	AU$ 47.37M	AU$ 18.03M	AU$ 18.14M	AU$ 15.81M	AU$ 13.28M	AU$ 13.28M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	AU$ 29.37M	AU$ 23.13M	AU$ 29.52M	AU$ 37.83M	AU$ 32.35M	AU$ 9.15M
Net Income From Continuing And Discontinued Operation	AU$ -17.53M	AU$ 129.62K	AU$ -23.13M	AU$ -21.69M	AU$ -13.74M	AU$ -1.43M
Normalized Income	AU$ -17.53M	AU$ -2.61M	AU$ -23.13M	AU$ -21.69M	AU$ -13.74M	AU$ -1.43M
Interest Expense	AU$ 2.29M	AU$ 6.19M	AU$ 8.85M	AU$ 3.82M	AU$ 1.28M	AU$ 289.78K
EBIT	AU$ -15.24M	AU$ 6.53M	AU$ -14.27M	AU$ -17.86M	AU$ -12.45M	AU$ -1.14M
EBITDA	AU$ -15.24M	AU$ 9.18M	AU$ -6.31M	AU$ -15.24M	AU$ -10.97M	AU$ -444.53K

Currency in AUD

Parnell Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing